MeSH term
Frequency | Condition_Probility | Base Sequence | 6 | 0.0 |
Chromosome Mapping | 5 | 0.0 |
DNA Primers | 3 | 0.0 |
Female | 6 | 0.0 |
Humans | 31 | 0.0 |
Pregnancy | 3 | 0.0 |
*Gene Expression | 2 | 0.0 |
Protein Synthesis Inhibitors/pharmacology | 2 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 22 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Signal Transduction | 6 | 0.0 |
Time Factors | 2 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Up-Regulation | 2 | 0.0 |
Animals | 18 | 0.0 |
Brain/metabolism | 3 | 0.0 |
Calcineurin/*metabolism | 2 | 12.0 |
Cell Division/drug effects | 2 | 0.0 |
Cell Line | 3 | 0.0 |
Gene Expression Regulation/drug effects | 2 | 0.0 |
Hamsters | 3 | 0.0 |
Hydrogen Peroxide/pharmacology | 2 | 0.0 |
Ionophores/pharmacology | 3 | 2.0 |
Muscle Proteins/genetics/*physiology | 2 | 25.0 |
Oxidants/pharmacology | 2 | 3.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Rats | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 13 | 0.0 |
Transfection | 2 | 0.0 |
Muscle Proteins/*genetics | 5 | 3.0 |
Down Syndrome | 2 | 33.0 |
Electrophoretic Mobility Shift Assay | 2 | 0.0 |
Exons/genetics | 3 | 0.0 |
Muscle Proteins/genetics/*metabolism | 3 | 12.0 |
*Transcription, Genetic | 2 | 0.0 |
Calcineurin/antagonists & inhibitors/metabolism | 3 | 50.0 |
Cells, Cultured | 4 | 0.0 |
DNA-Binding Proteins/metabolism | 4 | 0.0 |
Endothelium, Vascular/cytology | 2 | 0.0 |
*Gene Expression Regulation | 4 | 0.0 |
Genes, Reporter | 3 | 0.0 |
Muscle Proteins/*genetics/metabolism | 2 | 10.0 |
*Nuclear Proteins | 4 | 0.0 |
Signal Transduction/physiology | 2 | 0.0 |
Transcription Factors/metabolism | 3 | 0.0 |
Blotting, Northern | 5 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Male | 4 | 0.0 |
Protein Binding | 4 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
*Gene Expression Regulation, Developmental | 2 | 0.0 |
Gene Library | 2 | 0.0 |
Mice | 7 | 0.0 |
Amino Acid Sequence | 9 | 0.0 |
DNA, Complementary/chemistry/genetics | 2 | 0.0 |
Expressed Sequence Tags | 2 | 0.0 |
Molecular Sequence Data | 12 | 0.0 |
Proteins/genetics | 2 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Amino Acid | 8 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
COS Cells | 2 | 0.0 |
Down Syndrome/*genetics | 6 | 8.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Exons | 5 | 0.0 |
Proteins/*genetics | 3 | 0.0 |
Carrier Proteins/*genetics | 2 | 0.0 |
Polymerase Chain Reaction/*methods | 3 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
*Chromosomes, Human, Pair 21 | 3 | 1.0 |
*Muscle Proteins | 3 | 1.0 |
Chromosomes, Human, Pair 21 | 2 | 1.0 |
*Protein Biosynthesis | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Comparative Study | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Gene Expression Regulation/genetics/physiology | 2 | 7.0 |
Phosphorylation | 2 | 0.0 |
Chromosomes, Human, Pair 21/genetics | 2 | 4.0 |
Reproducibility of Results | 2 | 0.0 |
Calcineurin/*antagonists & inhibitors/metabolism | 2 | 66.0 |
Amino Acid Motifs/genetics | 2 | 3.0 |
Cercopithecus aethiops | 2 | 0.0 |
